Global Preclinical In-vivo Imaging Market Research Report 2023

Report ID: 1891595 | Published Date: Oct 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Preclinical In-vivo Imaging Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Optical Imaging Systems
        1.2.3 Micro-Ultrasound Systems
        1.2.4 Preclinical Nuclear Imaging Systems
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Preclinical In-vivo Imaging Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Research & Development
        1.3.3 Drug Discovery
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Preclinical In-vivo Imaging Market Perspective (2017-2028)
    2.2 Preclinical In-vivo Imaging Growth Trends by Region
        2.2.1 Preclinical In-vivo Imaging Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Preclinical In-vivo Imaging Historic Market Size by Region (2017-2022)
        2.2.3 Preclinical In-vivo Imaging Forecasted Market Size by Region (2023-2028)
    2.3 Preclinical In-vivo Imaging Market Dynamics
        2.3.1 Preclinical In-vivo Imaging Industry Trends
        2.3.2 Preclinical In-vivo Imaging Market Drivers
        2.3.3 Preclinical In-vivo Imaging Market Challenges
        2.3.4 Preclinical In-vivo Imaging Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Preclinical In-vivo Imaging Players by Revenue
        3.1.1 Global Top Preclinical In-vivo Imaging Players by Revenue (2017-2022)
        3.1.2 Global Preclinical In-vivo Imaging Revenue Market Share by Players (2017-2022)
    3.2 Global Preclinical In-vivo Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Preclinical In-vivo Imaging Revenue
    3.4 Global Preclinical In-vivo Imaging Market Concentration Ratio
        3.4.1 Global Preclinical In-vivo Imaging Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Preclinical In-vivo Imaging Revenue in 2021
    3.5 Preclinical In-vivo Imaging Key Players Head office and Area Served
    3.6 Key Players Preclinical In-vivo Imaging Product Solution and Service
    3.7 Date of Enter into Preclinical In-vivo Imaging Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical In-vivo Imaging Breakdown Data by Type
    4.1 Global Preclinical In-vivo Imaging Historic Market Size by Type (2017-2022)
    4.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Type (2023-2028)
5 Preclinical In-vivo Imaging Breakdown Data by Application
    5.1 Global Preclinical In-vivo Imaging Historic Market Size by Application (2017-2022)
    5.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Preclinical In-vivo Imaging Market Size (2017-2028)
    6.2 North America Preclinical In-vivo Imaging Market Size by Country (2017-2022)
    6.3 North America Preclinical In-vivo Imaging Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Preclinical In-vivo Imaging Market Size (2017-2028)
    7.2 Europe Preclinical In-vivo Imaging Market Size by Country (2017-2022)
    7.3 Europe Preclinical In-vivo Imaging Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Preclinical In-vivo Imaging Market Size (2017-2028)
    8.2 Asia-Pacific Preclinical In-vivo Imaging Market Size by Country (2017-2022)
    8.3 Asia-Pacific Preclinical In-vivo Imaging Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Preclinical In-vivo Imaging Market Size (2017-2028)
    9.2 Latin America Preclinical In-vivo Imaging Market Size by Country (2017-2022)
    9.3 Latin America Preclinical In-vivo Imaging Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Preclinical In-vivo Imaging Market Size (2017-2028)
    10.2 Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2017-2022)
    10.3 Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bruker
        11.1.1 Bruker Company Detail
        11.1.2 Bruker Business Overview
        11.1.3 Bruker Preclinical In-vivo Imaging Introduction
        11.1.4 Bruker Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.1.5 Bruker Recent Development
    11.2 Siemens
        11.2.1 Siemens Company Detail
        11.2.2 Siemens Business Overview
        11.2.3 Siemens Preclinical In-vivo Imaging Introduction
        11.2.4 Siemens Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.2.5 Siemens Recent Development
    11.3 TriFoil Imaging
        11.3.1 TriFoil Imaging Company Detail
        11.3.2 TriFoil Imaging Business Overview
        11.3.3 TriFoil Imaging Preclinical In-vivo Imaging Introduction
        11.3.4 TriFoil Imaging Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.3.5 TriFoil Imaging Recent Development
    11.4 PerkinElmer
        11.4.1 PerkinElmer Company Detail
        11.4.2 PerkinElmer Business Overview
        11.4.3 PerkinElmer Preclinical In-vivo Imaging Introduction
        11.4.4 PerkinElmer Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.4.5 PerkinElmer Recent Development
    11.5 Fujifilm VisualSonics
        11.5.1 Fujifilm VisualSonics Company Detail
        11.5.2 Fujifilm VisualSonics Business Overview
        11.5.3 Fujifilm VisualSonics Preclinical In-vivo Imaging Introduction
        11.5.4 Fujifilm VisualSonics Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.5.5 Fujifilm VisualSonics Recent Development
    11.6 MILabs
        11.6.1 MILabs Company Detail
        11.6.2 MILabs Business Overview
        11.6.3 MILabs Preclinical In-vivo Imaging Introduction
        11.6.4 MILabs Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.6.5 MILabs Recent Development
    11.7 Mediso
        11.7.1 Mediso Company Detail
        11.7.2 Mediso Business Overview
        11.7.3 Mediso Preclinical In-vivo Imaging Introduction
        11.7.4 Mediso Revenue in Preclinical In-vivo Imaging Business (2017-2022)
        11.7.5 Mediso Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Preclinical In-vivo Imaging Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Optical Imaging Systems
    Table 3. Key Players of Micro-Ultrasound Systems
    Table 4. Key Players of Preclinical Nuclear Imaging Systems
    Table 5. Key Players of Other
    Table 6. Global Preclinical In-vivo Imaging Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Preclinical In-vivo Imaging Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Preclinical In-vivo Imaging Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Preclinical In-vivo Imaging Market Share by Region (2017-2022)
    Table 10. Global Preclinical In-vivo Imaging Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Preclinical In-vivo Imaging Market Share by Region (2023-2028)
    Table 12. Preclinical In-vivo Imaging Market Trends
    Table 13. Preclinical In-vivo Imaging Market Drivers
    Table 14. Preclinical In-vivo Imaging Market Challenges
    Table 15. Preclinical In-vivo Imaging Market Restraints
    Table 16. Global Preclinical In-vivo Imaging Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Preclinical In-vivo Imaging Market Share by Players (2017-2022)
    Table 18. Global Top Preclinical In-vivo Imaging Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical In-vivo Imaging as of 2021)
    Table 19. Ranking of Global Top Preclinical In-vivo Imaging Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Preclinical In-vivo Imaging Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Preclinical In-vivo Imaging Product Solution and Service
    Table 23. Date of Enter into Preclinical In-vivo Imaging Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Preclinical In-vivo Imaging Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Preclinical In-vivo Imaging Revenue Market Share by Type (2017-2022)
    Table 27. Global Preclinical In-vivo Imaging Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Preclinical In-vivo Imaging Revenue Market Share by Type (2023-2028)
    Table 29. Global Preclinical In-vivo Imaging Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Preclinical In-vivo Imaging Revenue Market Share by Application (2017-2022)
    Table 31. Global Preclinical In-vivo Imaging Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Preclinical In-vivo Imaging Revenue Market Share by Application (2023-2028)
    Table 33. North America Preclinical In-vivo Imaging Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Preclinical In-vivo Imaging Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Preclinical In-vivo Imaging Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Preclinical In-vivo Imaging Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Preclinical In-vivo Imaging Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Preclinical In-vivo Imaging Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Preclinical In-vivo Imaging Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Preclinical In-vivo Imaging Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bruker Company Detail
    Table 44. Bruker Business Overview
    Table 45. Bruker Preclinical In-vivo Imaging Product
    Table 46. Bruker Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 47. Bruker Recent Development
    Table 48. Siemens Company Detail
    Table 49. Siemens Business Overview
    Table 50. Siemens Preclinical In-vivo Imaging Product
    Table 51. Siemens Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 52. Siemens Recent Development
    Table 53. TriFoil Imaging Company Detail
    Table 54. TriFoil Imaging Business Overview
    Table 55. TriFoil Imaging Preclinical In-vivo Imaging Product
    Table 56. TriFoil Imaging Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 57. TriFoil Imaging Recent Development
    Table 58. PerkinElmer Company Detail
    Table 59. PerkinElmer Business Overview
    Table 60. PerkinElmer Preclinical In-vivo Imaging Product
    Table 61. PerkinElmer Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 62. PerkinElmer Recent Development
    Table 63. Fujifilm VisualSonics Company Detail
    Table 64. Fujifilm VisualSonics Business Overview
    Table 65. Fujifilm VisualSonics Preclinical In-vivo Imaging Product
    Table 66. Fujifilm VisualSonics Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 67. Fujifilm VisualSonics Recent Development
    Table 68. MILabs Company Detail
    Table 69. MILabs Business Overview
    Table 70. MILabs Preclinical In-vivo Imaging Product
    Table 71. MILabs Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 72. MILabs Recent Development
    Table 73. Mediso Company Detail
    Table 74. Mediso Business Overview
    Table 75. Mediso Preclinical In-vivo Imaging Product
    Table 76. Mediso Revenue in Preclinical In-vivo Imaging Business (2017-2022) & (US$ Million)
    Table 77. Mediso Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Preclinical In-vivo Imaging Market Share by Type: 2021 VS 2028
    Figure 2. Optical Imaging Systems Features
    Figure 3. Micro-Ultrasound Systems Features
    Figure 4. Preclinical Nuclear Imaging Systems Features
    Figure 5. Other Features
    Figure 6. Global Preclinical In-vivo Imaging Market Share by Application in 2021 & 2028
    Figure 7. Research & Development Case Studies
    Figure 8. Drug Discovery Case Studies
    Figure 9. Preclinical In-vivo Imaging Report Years Considered
    Figure 10. Global Preclinical In-vivo Imaging Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Preclinical In-vivo Imaging Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Preclinical In-vivo Imaging Market Share by Region: 2021 VS 2028
    Figure 13. Global Preclinical In-vivo Imaging Market Share by Players in 2021
    Figure 14. Global Top Preclinical In-vivo Imaging Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical In-vivo Imaging as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Preclinical In-vivo Imaging Revenue in 2021
    Figure 16. North America Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Preclinical In-vivo Imaging Market Share by Country (2017-2028)
    Figure 18. United States Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Preclinical In-vivo Imaging Market Share by Country (2017-2028)
    Figure 22. Germany Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Preclinical In-vivo Imaging Market Share by Region (2017-2028)
    Figure 30. China Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Preclinical In-vivo Imaging Market Share by Country (2017-2028)
    Figure 38. Mexico Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Preclinical In-vivo Imaging Market Share by Country (2017-2028)
    Figure 42. Turkey Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Preclinical In-vivo Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Bruker Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 45. Siemens Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 46. TriFoil Imaging Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 47. PerkinElmer Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 48. Fujifilm VisualSonics Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 49. MILabs Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 50. Mediso Revenue Growth Rate in Preclinical In-vivo Imaging Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bruker
Siemens
TriFoil Imaging
PerkinElmer
Fujifilm VisualSonics
MILabs
Mediso
Frequently Asked Questions
Preclinical In-vivo Imaging report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Preclinical In-vivo Imaging report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Preclinical In-vivo Imaging report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pulses Based Product

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More